Japanese Pharmacology & Therapeutics（JPT）
Vol.27 Suppl.4 1999
Phase 1 clinical study of pibutidine hydrochride
J. Azuma, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) ｓ973-90
Clinical study of pibutidine hydrochloride（IT-066）on peptic ulcer
－Early dose finding by open study－
K. Kobayashi, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s991-1008
Does finding study of pibutidine hydrochloride on peptic ulcer
K. Kobayashi, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1009-35
Clinical study of pibutidine hydrochloride（IT-066）on peptic ulcer
－A multicenter double-blind comparative study with famotidine－
K. Kobayashi, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1037-75
Clinical effect of pibutidine hydrochloride on recurrent ulcer after gastric surgery
T. Aoki, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1077-91
Clinical effect of pibutidine hydrochloride on endocrine function and healing in patients with gastric ulcer
T. Misawa, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1093-13
Clinical evaluation of pibutidine hydrochloride on reflux esophagitis
－Comparison of 20mg daily and 40mg daily－
T. Sekiguchi, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1115-26
Effect of IT-066（pibutidine hydrochloride） on gastric acid secretion（first report）
－Dose finding with 24 hours gastric juice－
M. Tada, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1127-35
Effect of IT-066（pibutidine hydrochloride） on gastric acid secretion（second report）
－Comparative study on UID evening dose and BID evening and morning dose with 24 hours gastric juice－
M. Tada, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1137-47
Acid suppression profile of pibutidine hydrochloride with 24-hour intragastric pH monitoring
－Comparison of treatment 40mg once daily and 20mg twice daily－
S. Asaki, et al.
Jpn Pharmacol Ther 1999 27(Suppl.4) s1149-55